Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FDA approves Ligand's Targretin Capsules for treatment of CTCL

Dec. 30, 1999

Warner-Lambert reports R&D progress in the area of kinase inhibitors

Dec. 30, 1999

Antiangiogenic fumagillin analogues in the pipeline at BioChem Pharma

Dec. 29, 1999

Mitsui presents differentiation-inducing agents

Dec. 29, 1999

BIM-46068: a pseudopeptide FTase inhibitor with promise for cancer Rx

Dec. 29, 1999

Millennium validates prostate cancer gene target as part of Lilly collaboration

Dec. 29, 1999

MGH team identifies TSP-2 as a novel endogenous antiangiogenic factor

Dec. 29, 1999

Sugen succeeds in designing a potent, orally active PK inhibitor with antitumor activity

Dec. 28, 1999

FDA clears Taxotere for marketing in NSCLC

Dec. 28, 1999

SuperGen, Abbott reach distribution agreement for anticancer drugs

Dec. 28, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...